CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma
Author
A Koumarianou
A Rinke
+46Â more
A. Arcella
A. M. Grimaldi
B Palermo
BL Mundy-Bosse
C Banissi
C. De Divitiis
C. von Arx
CG Moertel
D. Cicala
DP Lindholm
E. Simeone
ED Williams
EL Bravo
ES Newlands
ES Newlands
F. Tatangelo
G Schiavoni
G. M. Romano
Gastrointestinal Pathology Study Group of Korean Society of Pathologists Cho MY, Kim JM, et al
I Gounaris
I Poschke
J Vincent
JC Yao
JC Yao
JR Strosberg
JR Strosberg
L Galluzzi
L Ridolfi
M Caroli
ME Caplin
MH Kulke
Nisa
OL Chinot
P Nistico
P. A. Ascierto
PE Bernick
R. V. Iaffaioli
S Ekeblad
S Welin
S Welin
S. Tafuto
SA Milan
SE Combs
SE Combs
Tai-Gyu Kim Chang-Hyun Kim,Jung-Sun Park,Sung-Dong Park,Chung Kwon Kim, Dong-Sup Chung,and Yong-Kil Hong
Toumpanakis
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
Full text link
Crossref